Trial Profile
Naltrexone Randomized Controlled Trial for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 17 Nov 2021
Price :
$35
*
At a glance
- Drugs Naltrexone (Primary)
- Indications Fatigue
- Focus Therapeutic Use
- 12 Nov 2021 Status changed from completed to discontinued.
- 31 May 2019 Status changed from active, no longer recruiting to completed.
- 08 Feb 2018 Planned primary completion date changed from 1 Aug 2018 to 1 Dec 2018.